Treatment of hyperlipidemia.

Area of Science:

• Cardiovascular Medicine
• Epidemiology
• Preventive Cardiology

Background:

• The link between elevated cholesterol and coronary artery disease (CAD) is well-established, yet often underestimated by medical professionals.
• Epidemiologic studies consistently verify the association between serum cholesterol levels and CAD risk.

Purpose of the Study:

• To emphasize the critical importance of physician awareness regarding cholesterol's role in CAD.
• To highlight the benefits of cholesterol-lowering interventions in preventing cardiovascular events.

Main Methods:

• Analysis of data from major epidemiologic and clinical trials, including the Coronary Primary Prevention Trial.
• Evaluation of the impact of diet and drug therapy on cholesterol and low-density lipoprotein (LDL) levels.
• Assessment of cardiovascular outcomes such as myocardial infarction, angina, and need for coronary artery bypass surgery.

Main Results:

• Diet and drug therapy reduced cholesterol by 9% and LDL cholesterol by 12.5% in at-risk patients.
• A collective 19% reduction in CAD death or nonfatal myocardial infarctions was observed.
• Significant decreases in angina, electrocardiogram abnormalities, and bypass surgery incidence were noted.

Conclusions:

• Lowering cholesterol and LDL is essential for retarding atherosclerotic plaque growth.
• The ratio of total cholesterol or LDL to high-density lipoprotein (HDL) cholesterol is a key indicator of CAD risk.
• Annual cholesterol monitoring and timely intervention for high-risk individuals are vital for cardiovascular health.